SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008155
Filing Date
2018-10-31
Accepted
2018-10-31 16:08:48
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbbp-20180930x10q.htm 10-Q 1684931
2 EX-31.1 sbbp-20180930ex3117646d3.htm EX-31.1 17807
3 EX-31.2 sbbp-20180930ex312ff7fd3.htm EX-31.2 17754
4 EX-32.1 sbbp-20180930ex321823855.htm EX-32.1 17620
  Complete submission text file 0001558370-18-008155.txt   6386796

Data Files

Seq Description Document Type Size
5 EX-101.INS sbbp-20180930.xml EX-101.INS 1255748
6 EX-101.SCH sbbp-20180930.xsd EX-101.SCH 57133
7 EX-101.CAL sbbp-20180930_cal.xml EX-101.CAL 53018
8 EX-101.DEF sbbp-20180930_def.xml EX-101.DEF 171255
9 EX-101.LAB sbbp-20180930_lab.xml EX-101.LAB 484029
10 EX-101.PRE sbbp-20180930_pre.xml EX-101.PRE 352073
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-Q | Act: 34 | File No.: 001-37569 | Film No.: 181150394
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences